144 related articles for article (PubMed ID: 31328811)
21. Overexpression of HIF-2α-Dependent NEAT1 Promotes the Progression of Non-Small Cell Lung Cancer through miR-101-3p/SOX9/Wnt/β-Catenin Signal Pathway.
Kong X; Zhao Y; Li X; Tao Z; Hou M; Ma H
Cell Physiol Biochem; 2019; 52(3):368-381. PubMed ID: 30845377
[TBL] [Abstract][Full Text] [Related]
22. Down-regulation of miR-675-5p contributes to tumor progression and development by targeting pro-tumorigenic GPR55 in non-small cell lung cancer.
He D; Wang J; Zhang C; Shan B; Deng X; Li B; Zhou Y; Chen W; Hong J; Gao Y; Chen Z; Duan C
Mol Cancer; 2015 Apr; 14():73. PubMed ID: 25889562
[TBL] [Abstract][Full Text] [Related]
23. miR-330-3p controls cell proliferation by targeting early growth response 2 in non-small-cell lung cancer.
Liu X; Shi H; Liu B; Li J; Liu Y; Yu B
Acta Biochim Biophys Sin (Shanghai); 2015 Jun; 47(6):431-40. PubMed ID: 25935837
[TBL] [Abstract][Full Text] [Related]
24. microRNA-338-3p functions as a tumor suppressor in human non‑small‑cell lung carcinoma and targets Ras-related protein 14.
Sun J; Feng X; Gao S; Xiao Z
Mol Med Rep; 2015 Feb; 11(2):1400-6. PubMed ID: 25374067
[TBL] [Abstract][Full Text] [Related]
25. microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C.
Hu J; Cheng Y; Li Y; Jin Z; Pan Y; Liu G; Fu S; Zhang Y; Feng K; Feng Y
Eur J Cancer; 2014 Sep; 50(13):2336-50. PubMed ID: 25001183
[TBL] [Abstract][Full Text] [Related]
26. Long noncoding RNA LINC-PINT inhibits non-small cell lung cancer progression through sponging miR-218-5p/PDCD4.
Zhang L; Hu J; Li J; Yang Q; Hao M; Bu L
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1595-1602. PubMed ID: 31010333
[TBL] [Abstract][Full Text] [Related]
27. MiR-770 inhibits tumorigenesis and EMT by targeting JMJD6 and regulating WNT/β-catenin pathway in non-small cell lung cancer.
Zhang Z; Yang Y; Zhang X
Life Sci; 2017 Nov; 188():163-171. PubMed ID: 28882645
[TBL] [Abstract][Full Text] [Related]
28. Luteolin Inhibits Tumorigenesis and Induces Apoptosis of Non-Small Cell Lung Cancer Cells via Regulation of MicroRNA-34a-5p.
Jiang ZQ; Li MH; Qin YM; Jiang HY; Zhang X; Wu MH
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29393891
[TBL] [Abstract][Full Text] [Related]
29. miR-338-3p suppresses epithelial-mesenchymal transition and metastasis in human nonsmall cell lung cancer.
Hong-Yuan W; Xiao-Ping C
Indian J Cancer; 2015 Dec; 52 Suppl 3():E168-71. PubMed ID: 27453416
[TBL] [Abstract][Full Text] [Related]
30. Knockdown of Lncrna PVT1 Enhances Radiosensitivity in Non-Small Cell Lung Cancer by Sponging Mir-195.
Wu D; Li Y; Zhang H; Hu X
Cell Physiol Biochem; 2017; 42(6):2453-2466. PubMed ID: 28848163
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-661 promotes non-small cell lung cancer progression by directly targeting RUNX3.
Wang Y; Li Y; Wu B; Shi C; Li C
Mol Med Rep; 2017 Aug; 16(2):2113-2120. PubMed ID: 28656235
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-5195-3p plays a suppressive role in cell proliferation, migration and invasion by targeting MYO6 in human non-small cell lung cancer.
Yang Q
Biosci Biotechnol Biochem; 2019 Feb; 83(2):212-220. PubMed ID: 30387375
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-187-5p suppresses cancer cell progression in non-small cell lung cancer (NSCLC) through down-regulation of CYP1B1.
Mao M; Wu Z; Chen J
Biochem Biophys Res Commun; 2016 Sep; 478(2):649-55. PubMed ID: 27495872
[TBL] [Abstract][Full Text] [Related]
34. miR-205 promotes the growth, metastasis and chemoresistance of NSCLC cells by targeting PTEN.
Lei L; Huang Y; Gong W
Oncol Rep; 2013 Dec; 30(6):2897-902. PubMed ID: 24084898
[TBL] [Abstract][Full Text] [Related]
35. miR-4317 suppresses non-small cell lung cancer (NSCLC) by targeting fibroblast growth factor 9 (FGF9) and cyclin D2 (CCND2).
He X; Chen SY; Yang Z; Zhang J; Wang W; Liu MY; Niu Y; Wei XM; Li HM; Hu WN; Sun GG
J Exp Clin Cancer Res; 2018 Sep; 37(1):230. PubMed ID: 30227870
[TBL] [Abstract][Full Text] [Related]
36. SUMO1P3 is associated clinical progression and facilitates cell migration and invasion through regulating miR-136 in non-small cell lung cancer.
Zhang Y; Li Y; Han L; Zhang P; Sun S
Biomed Pharmacother; 2019 May; 113():108686. PubMed ID: 30851548
[TBL] [Abstract][Full Text] [Related]
37. FBXL3 is regulated by miRNA-4735-3p and suppresses cell proliferation and migration in non-small cell lung cancer.
Wang D; Han X; Li C; Bai W
Pathol Res Pract; 2019 Feb; 215(2):358-365. PubMed ID: 30594330
[TBL] [Abstract][Full Text] [Related]
38. LncRNA-UCA1 exerts oncogenic functions in non-small cell lung cancer by targeting miR-193a-3p.
Nie W; Ge HJ; Yang XQ; Sun X; Huang H; Tao X; Chen WS; Li B
Cancer Lett; 2016 Feb; 371(1):99-106. PubMed ID: 26655272
[TBL] [Abstract][Full Text] [Related]
39. MiR-652-3p is upregulated in non-small cell lung cancer and promotes proliferation and metastasis by directly targeting Lgl1.
Yang W; Zhou C; Luo M; Shi X; Li Y; Sun Z; Zhou F; Chen Z; He J
Oncotarget; 2016 Mar; 7(13):16703-15. PubMed ID: 26934648
[TBL] [Abstract][Full Text] [Related]
40. MiR-454 promotes the progression of human non-small cell lung cancer and directly targets PTEN.
Zhu DY; Li XN; Qi Y; Liu DL; Yang Y; Zhao J; Zhang CY; Wu K; Zhao S
Biomed Pharmacother; 2016 Jul; 81():79-85. PubMed ID: 27261580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]